It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The complexity of affected brain regions and cell types is a challenge for Huntington’s disease (HD) treatment. Here we use single nucleus RNA sequencing to investigate molecular pathology in the cortex and striatum from R6/2 mice and human HD post-mortem tissue. We identify cell type-specific and -agnostic signatures suggesting oligodendrocytes (OLs) and oligodendrocyte precursors (OPCs) are arrested in intermediate maturation states. OL-lineage regulators OLIG1 and OLIG2 are negatively correlated with CAG length in human OPCs, and ATACseq analysis of HD mouse NeuN-negative cells shows decreased accessibility regulated by OL maturation genes. The data implicates glucose and lipid metabolism in abnormal cell maturation and identify PRKCE and Thiamine Pyrophosphokinase 1 (TPK1) as central genes. Thiamine/biotin treatment of R6/1 HD mice to compensate for TPK1 dysregulation restores OL maturation and rescues neuronal pathology. Our insights into HD OL pathology spans multiple brain regions and link OL maturation deficits to abnormal thiamine metabolism.
Here the authors evaluate single cell gene expression from mouse and human Huntington’s disease brains, finding incomplete oligodendrocyte maturation and pathways involved. Treating mice with thiamine/biotin ameliorates molecular pathology.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details













1 UCI MIND, University of California Irvine, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243)
2 Columbia University Irving Medical Center, Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons, New York, USA (GRID:grid.239585.0) (ISNI:0000 0001 2285 2675)
3 University of California Irvine, Department of Biological Chemistry, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243)
4 Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, USA (GRID:grid.116068.8) (ISNI:0000 0001 2341 2786)
5 Columbia University Irving Medical Center, Department of Neurology, Vagelos College of Physicians and Surgeons, New York, USA (GRID:grid.239585.0) (ISNI:0000 0001 2285 2675)
6 Advanced Science Research Center at the City University of New York, New York, USA (GRID:grid.212340.6) (ISNI:0000000122985718)
7 University of California Irvine, Department of Psychiatry and Human Behavior, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243)
8 University of California Irvine, Department of Neurobiology and Behavior, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243)
9 University of California Irvine, Department of Pathology, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243)
10 Columbia University Irving Medical Center, Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons, New York, USA (GRID:grid.239585.0) (ISNI:0000 0001 2285 2675); Columbia University Irving Medical Center, New York City, Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, New York, USA (GRID:grid.239585.0) (ISNI:0000 0001 2285 2675)
11 Lewis-Sigler Institute for Integrative Genomics, Princeton, USA (GRID:grid.239585.0)
12 UCI MIND, University of California Irvine, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243); University of California Irvine, Department of Neurobiology and Behavior, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243)
13 UCI MIND, University of California Irvine, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243); University of California Irvine, Department of Biological Chemistry, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243); University of California Irvine, Department of Psychiatry and Human Behavior, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243); University of California Irvine, Department of Neurobiology and Behavior, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243); Sue and Bill Gross Stem Cell Center University of California Irvine, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243)